FR2255056B1 - - Google Patents

Info

Publication number
FR2255056B1
FR2255056B1 FR7442457A FR7442457A FR2255056B1 FR 2255056 B1 FR2255056 B1 FR 2255056B1 FR 7442457 A FR7442457 A FR 7442457A FR 7442457 A FR7442457 A FR 7442457A FR 2255056 B1 FR2255056 B1 FR 2255056B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7442457A
Other versions
FR2255056A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14373873A external-priority patent/JPS5432774B2/ja
Priority claimed from JP372674A external-priority patent/JPS5418242B2/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2255056A1 publication Critical patent/FR2255056A1/fr
Application granted granted Critical
Publication of FR2255056B1 publication Critical patent/FR2255056B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7442457A 1973-12-25 1974-12-23 Expired FR2255056B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14373873A JPS5432774B2 (fr) 1973-12-25 1973-12-25
JP372674A JPS5418242B2 (fr) 1973-12-29 1973-12-29

Publications (2)

Publication Number Publication Date
FR2255056A1 FR2255056A1 (fr) 1975-07-18
FR2255056B1 true FR2255056B1 (fr) 1978-09-01

Family

ID=26337362

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7442457A Expired FR2255056B1 (fr) 1973-12-25 1974-12-23

Country Status (11)

Country Link
US (1) US4024174A (fr)
AU (1) AU7678474A (fr)
CA (1) CA1066699A (fr)
CH (3) CH613684A5 (fr)
DE (1) DE2460285A1 (fr)
FI (1) FI373274A (fr)
FR (1) FR2255056B1 (fr)
GB (1) GB1483240A (fr)
LU (1) LU71563A1 (fr)
NL (1) NL189350C (fr)
SE (1) SE423541B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525282A (en) * 1975-08-08 1978-09-20 Ono Pharmaceutical Co 16-chloroprostaglandin analogues
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
DE2830079A1 (de) * 1978-07-08 1980-01-17 Hoechst Ag Neue prostaglandinderivate der delta 2,4-11-desoxy-pge-reihe
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
US4360688A (en) * 1981-05-21 1982-11-23 American Cyanamid Company Precursors and synthesis of d1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
US5166369A (en) * 1981-05-21 1992-11-24 American Cyanamid Company Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792803A (fr) * 1971-12-17 1973-03-30 Erba Carlo Spa Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant
CH599147A5 (en) * 1973-07-09 1978-05-12 Sandoz Ag Long-acting synthetic prostaglandins

Also Published As

Publication number Publication date
FI373274A (fr) 1975-06-26
LU71563A1 (fr) 1975-08-20
DE2460285A1 (de) 1975-07-03
GB1483240A (en) 1977-08-17
US4024174A (en) 1977-05-17
CH609043A5 (en) 1979-02-15
FR2255056A1 (fr) 1975-07-18
CH613444A5 (en) 1979-09-28
SE423541B (sv) 1982-05-10
SE7416251L (fr) 1975-06-26
CA1066699A (fr) 1979-11-20
NL189350C (nl) 1993-03-16
CH613684A5 (en) 1979-10-15
NL7416804A (nl) 1975-06-27
AU7678474A (en) 1976-06-24
NL189350B (nl) 1992-10-16

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU465372B2 (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
AU476714B2 (fr)
FR2255056B1 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU476873B1 (fr)
AR193950A1 (fr)
AR200885A1 (fr)
AU471461B2 (fr)
AR196382A1 (fr)
AR200256A1 (fr)
AR197627A1 (fr)
AR195311A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse